glp 1 agonists and pancreatitis Reconciling GLP-1s GLP-1–Based Therapy for Diabetes: What
Description
Titration, the process of slowly increasing dosage over time and only when the medication is well-tolerated, helps manage GLP-1 side effects

Its the way we treat heart failure, HIV, tuberculosis, blood pressure, and many other diseases in medicine

For all pair wise comparisons, Risk ratios (RRs) and 95% Confidence Interval (CI) were used as the meta-analytic measure of association between treatment and the incidence of events

Both compounds require gradual dose escalation
Ludvik B, Giorgino F, Jodar E, Frias JP, Fernandez Lando L, Brown K, et al

Recent cryogenic electron microscope (cryo-EM) structures of the human and rabbit GLP-1Rs (bound to exendin-p5 and GLP-1, respectively) indicate that residue 33 does not interact with peptide agonists but extends towards solvent (Fig
